Skip to main content
. 2023 Oct 10;14(2):10.24926/iip.v14i2.5454. doi: 10.24926/iip.v14i2.5454

Table 5.

Up-to-Date Vaccination Rates at Baseline and End of Study

Vaccine Baseline Up-to-date n (%) End of Study Up-to-date n (%) Statistical Significance
Pneumococcal 2,456 (67.7) 2,831 (78.1) p < 0.001
Tdap/Td 3,940 (63.5) 4,491 (72.3) p < 0.001
Zoster 589 (10.6) 1,558 (27.9) p < 0.001

Tdap/Td = tetanus and diphtheria with or without pertussis; Pneumococcal includes PCV13 (pneumococcal conjugate vaccine) and PPSV23 (pneumococcal polysaccharide vaccine).